van Schaik RHN - Search Results

1

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, Marquet P, Molinaro M, Noceti O, Pattanaik S, Pawinski T, Seger C, Shipkova M, Swen JJ, van Gelder T, Venkataramanan R, Wieland E, Woillard JB, Zwart TC, Barten MJ, Budde K, Dieterlen MT, Elens L, Haufroid V, Masuda S, Millan O, Mizuno T, Moes DJAR, Oellerich M, Picard N, Salzmann L, Tönshoff B, van Schaik RHN, Vethe NT, Vinks AA, Wallemacq P, Åsberg A, Langman LJ. Bergan S, et al. Among authors: van gelder t, van schaik rhn. Ther Drug Monit. 2021 Apr 1;43(2):150-200. doi: 10.1097/FTD.0000000000000871. Ther Drug Monit. 2021. PMID: 33711005 Review.

2

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.

Hesselink DA, van Schaik RH, van der Heiden IP, van der Werf M, Gregoor PJ, Lindemans J, Weimar W, van Gelder T. Hesselink DA, et al. Clin Pharmacol Ther. 2003 Sep;74(3):245-54. doi: 10.1016/S0009-9236(03)00168-1. Clin Pharmacol Ther. 2003. PMID: 12966368

3

Pharmacogenetics in immunosuppressive therapy: the best thing since TDM?

van Gelder T, Hesselink DA, van Hest RM, Mathôt RA, van Schaik R. van Gelder T, et al. Ther Drug Monit. 2004 Aug;26(4):343-6. doi: 10.1097/00007691-200408000-00001. Ther Drug Monit. 2004. PMID: 15257061 Review. No abstract available.

4

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.

Hesselink DA, van Gelder T, van Schaik RH, Balk AH, van der Heiden IP, van Dam T, van der Werf M, Weimar W, Mathot RA. Hesselink DA, et al. Clin Pharmacol Ther. 2004 Dec;76(6):545-56. doi: 10.1016/j.clpt.2004.08.022. Clin Pharmacol Ther. 2004. PMID: 15592326

5

The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?

Hesselink DA, van Gelder T, van Schaik RH. Hesselink DA, et al. Pharmacogenomics. 2005 Jun;6(4):323-37. doi: 10.1517/14622416.6.4.323. Pharmacogenomics. 2005. PMID: 16004552 Review.

6

Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants.

Bijl MJ, Visser LE, Hofman A, Vulto AG, van Gelder T, Stricker BH, van Schaik RH. Bijl MJ, et al. Br J Clin Pharmacol. 2008 Apr;65(4):558-64. doi: 10.1111/j.1365-2125.2007.03052.x. Epub 2007 Dec 7. Br J Clin Pharmacol. 2008. PMID: 18070221 Free PMC article.

7

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.

Hesselink DA, van Schaik RH, van Agteren M, de Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DR, Pisarski P, Le Meur Y, Mamelok RD, van Gelder T. Hesselink DA, et al. Pharmacogenet Genomics. 2008 Apr;18(4):339-48. doi: 10.1097/FPC.0b013e3282f75f88. Pharmacogenet Genomics. 2008. PMID: 18334918 Clinical Trial.

8

A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine.

Hesselink DA, van Schaik RH, Nauta J, van Gelder T. Hesselink DA, et al. Pharmacogenomics. 2008 Jun;9(6):783-9. doi: 10.2217/14622416.9.6.783. Pharmacogenomics. 2008. PMID: 18518855

9

AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.

van Agteren M, Armstrong VW, van Schaik RH, de Fijter H, Hartmann A, Zeier M, Budde K, Kuypers D, Pisarski P, Le Meur Y, van der Werf M, Mamelok RD, Oellerich M, van Gelder T. van Agteren M, et al. Ther Drug Monit. 2008 Aug;30(4):439-44. doi: 10.1097/FTD.0b013e318180c709. Ther Drug Monit. 2008. PMID: 18641546 Clinical Trial.

10

UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.

van Schaik RH, van Agteren M, de Fijter JW, Hartmann A, Schmidt J, Budde K, Kuypers D, Le Meur Y, van der Werf M, Mamelok R, van Gelder T. van Schaik RH, et al. Clin Pharmacol Ther. 2009 Sep;86(3):319-27. doi: 10.1038/clpt.2009.83. Epub 2009 Jun 3. Clin Pharmacol Ther. 2009. PMID: 19494809 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

409 results

Search Page